The pacemaker is an artificial or non-natural
device implanted in the chest that produces low-energy electrical pulses to
control the abnormal heart rhythm. They are used in the medical conditions for
instance arrhythmia, heart block, atrial fibrillation, and long QT syndrome.
The devices are the preferred alternative of treatment in cardiovascular
diseases due to non-invasive nature of these devices. The use of pacemaker
devices comes with the numerous complications like operational failure, due to
use of battery depletion, random component failure or mishandling, connected
with the temporary external pacemakers.
According to study, “Pacemaker
Market - Global Forecasts upto 2024” some of the major companies that
are currently working in the pacemaker market are Abbott Laboratories, Inc.
(St. Jude Medical, Inc.), Medtronic, Boston Scientific Corporation, Oscor Inc.,
SORIN Group, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation,
Livanova, Lepu Medical Technology Co. Ltd., Osypka Medical GmbH, Qinming
Medical, Vitatron Holding B.V., Medico, S.p.A, Shree Pacetronix Ltd. Several
market vendors in the emerging economies such as Middle East & Asia-Pacific
have resulted into products compatible with concert levels so that of high-end
implantable cardiac pacemakers at reasonable costs can be manufactured.
Based on type, the pacemakers market is
segmented into conventional pacemakers and MRI compatible pacemakers. Based on
device type, market is separated into external pacemakers and implantable
pacemakers. The external cardiac pacemaker is used for momentary pacing &
requires a fully furbished medical facility. The implantable pacemaker device
is located under the skin on left side of the chest, and is connected with
leads guided by a blood vessel to the heart. Based on technology, market is
classified into single chamber pacemakers, dual chamber pacemakers and
biventricular or CRT pacemakers. Single-chamber pacemaker fixes pulse generator
to one of the chambers of heart. Dual-chamber pacemaker includes two leads,
which are placed in ventricle and right atrium. Additionally, biventricular
pacemaker is used in patient that illustrates lack of synchronization between
contractions of the right & a left ventricle, which is a most ordinary
condition, known as ventricular desynchrony. Based on usage, market is
classified into heart block, arrhythmia, atrial fibrillation, tachycardia,
bradycardia and long QT syndrome. The arrhythmia heart is not able to pump
sufficient blood to the other parts of the body, which causes fainting &
fatigue. Arrhythmia is of two types, bradycardia and tachycardia. When the
heart beat is too slow it is termed as bradycardia and when it is too slow it
is known as tachycardia. Moreover, based on end-user type, market is described
as ambulatory surgical centers (ASCs) and hospitals & cardiac centers.
The global pacemaker market is driven by the
increase in technological advancements. Some other driven aspects are
increasing burden of cardiovascular diseases (CVD), combined efforts of
government & domestic players, various supportive government initiatives,
food reimbursement facilities, increasing research & development (R&D)
investments and increasing aging population. Apart from benefits, some of the
restraints include unfavorable reimbursement scenario, high cost of pacemakers,
stringent regulatory approval process, side effect of pacemakers and lack of
skilled healthcare professionals. Furthermore, market is also impacted by the
key challenges that include frequent product recalls and shortage of cardiac
surgeons. Moreover, the key opportunities associated include implantable micro
pacemakers designed for fetal use and emerging markets.
In the upcoming years, future of global
pacemaker market is expected to be bright due to increase in the availability
of skilled physicians & healthcare practitioners.
For more information, click on the
link below:
Contact Us:
Ken Research
Ankur
Gupta, Head Marketing & Communications
+91
9015378249
